Angina Pectoris Drugs Market Size, Share & Trends Report

Angina Pectoris Drugs Market Size, Share & Trends Analysis Report By Type (Stable Angina, Unstable Angina), By Drug Class (Beta Blockers, Anticoagulants), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-2-68038-045-3
Number of Report Pages: 100
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Angina Pectoris Drugs Market Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Million)
  3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
  3.4. Angina Pectoris Drugs Market Analysis Tools
  3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and Social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Angina Pectoris Drugs Market: Type Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Angina Pectoris Drugs Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  4.3. Stable Angina
  4.3.1. Stable Angina Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4. Unstable Angina
  4.4.1. Unstable Angina Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5. Microvascular Angina
  4.5.1. Microvascular Angina Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.6. Prinzmetal Angina
  4.6.1. Prinzmetal Angina Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Angina Pectoris Drugs Market: Drug Class Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Angina Pectoris Drugs Market: Drug Class Movement Analysis, 2023 & 2030 (USD Million)
  5.3. Beta Blockers
  5.3.1. Beta Blockers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.4. Calcium Antagonists
  5.4.1. Calcium Antagonists Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.5. Nitrates
  5.5.1. Nitrates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.6. Anticoagulants
  5.6.1. Anticoagulants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.7. Anti-Platelets
  5.7.1. Anti-Platelets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.8. Other Drug Classes
  5.8.1. Other Drug Classes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Angina Pectoris Drugs Market: Distribution Channel Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Angina Pectoris Drugs Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  6.3. Hospital Pharmacy
  6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4. Retail Pharmacy
  6.4.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5. Online Pharmacy
  6.5.1. Online Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Angina Pectoris Drugs Market: Regional Estimates & Trend Analysis
  7.1. Angina Pectoris Drugs Market Share, By Region, 2023 & 2030 (USD Million)
  7.2. North America
  7.2.1. North America Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.2. U.S.
  7.2.2.1. U.S. Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.3. Canada
  7.2.3.1. Canada Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.4. Mexico
  7.2.4.1. Mexico Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3. Europe
  7.3.1. Europe Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.2. UK
  7.3.2.1. UK Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.3. Germany
  7.3.3.1. Germany Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.4. France
  7.3.4.1. France Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.5. Italy
  7.3.5.1. Italy Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.6. Spain
  7.3.6.1. Spain Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.7. Denmark
  7.3.7.1. Denmark Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.8. Sweden
  7.3.8.1. Sweden Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.9. Norway
  7.3.9.1. Norway Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4. Asia Pacific
  7.4.1. Asia Pacific Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.2. Japan
  7.4.2.1. Japan Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.3. China
  7.4.3.1. China Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.4. India
  7.4.4.1. India Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.5. Australia
  7.4.5.1. Australia Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.6. South Korea
  7.4.6.1. South Korea Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.7. Thailand
  7.4.7.1. Thailand Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
  7.5.1. Latin America Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.2. Brazil
  7.5.2.1. Brazil Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.3. Argentina
  7.5.3.1. Argentina Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6. Middle East and Africa
  7.6.1. Middle East and Africa Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.2. South Africa
  7.6.2.1. South Africa Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.3. Saudi Arabia
  7.6.3.1. Saudi Arabia Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.4. UAE
  7.6.4.1. UAE Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.5. Kuwait
  7.6.5.1. Kuwait Angina Pectoris Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
  8.1. Recent Developments & Impact Analysis by Key Market Participants
  8.2. Company Categorization
  8.3. Company Heat Map Analysis
  8.4. Company Profiles
  8.4.1. Pfizer Inc.
  8.4.1.1. Participant’s Overview
  8.4.1.2. Financial Performance
  8.4.1.3. Product Benchmarking
  8.4.1.4. Recent Developments/Strategic Initiatives
  8.4.2. Bayer AG
  8.4.2.1. Participant’s Overview
  8.4.2.2. Financial Performance
  8.4.2.3. Product Benchmarking
  8.4.2.4. Recent Developments/Strategic Initiatives
  8.4.3. AstraZeneca
  8.4.3.1. Participant’s Overview
  8.4.3.2. Financial Performance
  8.4.3.3. Product Benchmarking
  8.4.3.4. Recent Developments/Strategic Initiatives
  8.4.4. Gilead Sciences
  8.4.4.1. Participant’s Overview
  8.4.4.2. Financial Performance
  8.4.4.3. Product Benchmarking
  8.4.4.4. Recent Developments/Strategic Initiatives
  8.4.5. Novartis AG
  8.4.5.1. Participant’s Overview
  8.4.5.2. Financial Performance
  8.4.5.3. Product Benchmarking
  8.4.5.4. Recent Developments/Strategic Initiatives
  8.4.6. GlaxoSmithKline Plc.
  8.4.6.1. Participant’s Overview
  8.4.6.2. Financial Performance
  8.4.6.3. Product Benchmarking
  8.4.6.4. Recent Developments/Strategic Initiatives
  8.4.7. Merck & Co., Inc.
  8.4.7.1. Participant’s Overview
  8.4.7.2. Financial Performance
  8.4.7.3. Product Benchmarking
  8.4.7.4. Recent Developments/Strategic Initiatives
  8.4.8. Amgen Inc.
  8.4.8.1. Participant’s Overview
  8.4.8.2. Financial Performance
  8.4.8.3. Product Benchmarking
  8.4.8.4. Recent Developments/Strategic Initiatives
  8.4.9. Eli Lilly and Company
  8.4.9.1. Participant’s Overview
  8.4.9.2. Financial Performance
  8.4.9.3. Product Benchmarking
  8.4.9.4. Recent Developments/Strategic Initiatives
  8.4.10. Otsuka Pharmaceutical Co., Ltd.
  8.4.10.1. Participant’s Overview
  8.4.10.2. Financial Performance
  8.4.10.3. Product Benchmarking
  8.4.10.4. Recent Developments/Strategic Initiatives
  8.4.11. Sanofi S.A.
  8.4.11.1. Participant’s Overview
  8.4.11.2. Financial Performance
  8.4.11.3. Product Benchmarking
  8.4.11.4. Recent Developments/Strategic Initiatives
  8.4.12. Boehringer Ingelheim International GmbH
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.